EuroPCR 2011

EuroPCR | May 17-20, 2011

Note that some of these links take you to a site outside of CardioSource.
CardioSource does not assume responsibility for content of external sites.

Real-World TAVI Results Deemed 'Excellent'

PARIS — As transcatheter aortic valve implantation moves into lower risk groups in real-world practice, the outcomes in multinational registry studies continue to support the use of the TAVI procedure.
- Read More

Dumping Durable Polymer Benefits Newer DES

PARIS — Taking permanent polymer out of the equation for drug-eluting stents doesn't hurt and may help long-term outcomes, according to a bevy of studies reported here.
- Read More
Novel Bare Metal Stent Ties With Leading DES

PARIS — A novel bare metal stent, albeit one with a "bioactive" surface, may be just as good as a leading drug-eluting stent, according to randomized trial results.
- Read More

Stenosis Dx Better With Special 3-D CT

PARIS — Functionally relevant coronary artery stenosis can be deduced noninvasively from specially-interpreted CT scans, improving accuracy of diagnosis, researchers found.
- Read More
Transapical TAVI Takes on Thicker Valves

PARIS — Apical implantation of aortic valves may allow thicker, potentially more durable, leaflets, according to researchers presenting early results with one such novel device.
- Read More

Novel Metal Stent Does Disappearing Act

PARIS — A novel drug-eluting stent may do away with the permanent metal jacket, according to early results with a bioabsorbable metal scaffold.
- Read More
Leaky Percutaneous Valves Hurt Outcomes

PARIS — Even less severe leaks in aortic valves replaced percutaneously may compromise patients outcomes, with poor prosthesis fit a common culprit, researchers found.
- Read More

Residual Platelet Reactivity Risky in ACS

PARIS — A poor response to clopidogrel (Plavix) during percutaneous coronary intervention (PCI) can predict poor outcomes in patients with acute coronary syndrome, an Italian study found.
- Read More
Closure Device Affirmed Effective

PARIS — A femoral artery closure device may reduce large hematomas and speed closure compared with manual compression of the catheter access wound, a randomized trial indicated.
- Read More
Renal Denervation Eyed for Wider Use

PARIS — Renal sympathetic nerve ablation looks promising against refractory hypertension and could find a place in treating heart failure as well as chronic kidney disease, according to experts here.
- Read More

Focus on Valves, BP in PCI

PARIS — New frontiers in percutaneous intervention for structural heart disease and hypertension are expected to generate most of the buzz at the EuroPCR meeting here.
- Read More